Eiger Biopharmaceuticals raises $7.1M
Eiger Biopharmaceuticals has raised $7.1 million in a first round of venture funding, according to Private Equity Hub. The Palo Alto, Calif. startup doesn’t have a website, and we don’t have any details about the company at this time. Investors include InterWest Partners and Vivo Ventures.
Next Story: National Payment Card Association raises $2M to lower debit fees
Previous Story: Iminlikewithyou names new chief executive
About the Author, Anthony Ha
Anthony is a senior editor at VentureBeat, as well as its reporter on media, advertising, and social networks. Before joining the site in 2008, Anthony worked at the Hollister Free Lance, where he won awards from the California Newspaper Publishers Association for breaking news coverage and writing. He attended Stanford University and now lives in San Francisco. Reach him at anthony@venturebeat.com. (All story pitches should also be sent to tips@venturebeat.com) You can also follow Anthony on Twitter.
